en

PRODUCT DETAIL

Carmustine Zentiva 100 mg

Code 2187D
MA number 44/0235/19-S
Product Form: plc fol 1x100 mg + 1x3 ml solv. (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD01 Carmustine
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.07.2019
Pediatric contraindication: Yes
PIL: PIL_Carmustine Zentiva 100 mg, plc fol_pôvodné rozpúšťadlo (bezvodý etanol)_09_2021.pdf  
SPC: SPC_Carmustine Zentiva 100 mg plc fol_pôvodné rozpúšťadlo (bezvodý etanol)_09_2021.pdf  
SPC: SPC_Carmustine Zentiva 100 mg_propylénglykol_rozpúšťadlo_09.2023.pdf  
PIL: PIL_Carmustine Zentiva 100 mg_propylénglykol_rozpúšťadlo_11.2023.pdf  
Safety feature Yes
Data update: 18.04.2024
eu-flag.png sk-flag.png